Public Profile

Grifols

Grifols, officially known as Grifols, S.A., is a global leader in the biopharmaceutical industry, headquartered in Barcelona, Spain (ES). Founded in 1940, the company has established a strong presence in key operational regions, including Europe, North America, and Latin America. Grifols specialises in the development of plasma-derived medicines, diagnostic solutions, and hospital products, with a commitment to improving patient health. The company is renowned for its innovative therapies, particularly in the treatment of rare and chronic diseases, setting it apart in a competitive market. Grifols has achieved significant milestones, including the expansion of its plasma collection network and advancements in immunology. With a robust market position, Grifols continues to be recognised for its contributions to healthcare, making it a trusted name in the biopharmaceutical sector.

DitchCarbon Score

How does Grifols's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

47

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Grifols's score of 47 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Grifols's reported carbon emissions

In 2023, Grifols reported total greenhouse gas emissions of approximately 106,459,000 kg CO2e from Scope 1, 98,106,000 kg CO2e from Scope 2, and 947,463,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 42% by 2030 from a 2022 baseline. Additionally, Grifols targets a 25% reduction in absolute Scope 3 emissions, which include emissions from purchased goods and services, capital goods, fuel- and energy-related activities, and upstream transportation and distribution, within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. Grifols is headquartered in Spain and operates within the pharmaceuticals, biotechnology, and life sciences sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820192020202120222023
Scope 1
98,043,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
Scope 2
120,493,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
Scope 3
77,388,000
00,000,000
00,000,000
0,000,000,000
0,000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Grifols's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Grifols is headquartered in ES, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Grifols is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Lam Research

US
Electrical machinery and apparatus n.e.c. (31)
Updated 5 days ago

Sanofi Pasteur SA

FR
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Beckman Coulter, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 28 days ago

B. Braun Melsungen AG

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated 9 days ago

Baxter

US
Health and social work services (85)
Updated 5 days ago

Hospira

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers